[Inborn errors of high-density lipoprotein metabolism]

Arnold von Eckardstein1

  • 1Institut für Klinische Chemie, Universitätsspital Zürich und Universität Zürich, Rämistrasse 100, 8091, Zürich, Schweiz. arnold.voneckardstein@usz.ch.

Der Internist
|November 6, 2019
PubMed

Insights

Both low and very high levels of high-density lipoprotein cholesterol (HDL-C) increase cardiovascular disease risk. Monogenic diseases affecting HDL-C levels require genetic diagnostics and management of complications.

Area of Science:

  • Cardiovascular Medicine
  • Human Genetics
  • Biochemistry

Background:

  • Abnormal high-density lipoprotein cholesterol (HDL-C) levels, both low and very high, are linked to increased atherosclerotic cardiovascular disease (ASCVD) risk and reduced life expectancy.
  • Common causes include underlying diseases, lifestyle factors, or medications, necessitating their exclusion.
  • Less frequently, monogenic disorders affecting genes like APOA1, ABCA1, LCAT, CETP, LIPC, and SCARB1 result in extreme HDL-C levels.

Purpose of the Study:

  • To highlight the significance of genetic and biochemical diagnostics in identifying monogenic causes of dysregulated HDL-C.
  • To outline clinical and laboratory indicators suggestive of monogenic HDL disorders.
  • To emphasize the importance of managing cardiovascular and renal complications in affected individuals.

Main Methods:

  • Review of literature on HDL-C metabolism, genetics, and associated diseases.
  • Analysis of clinical presentations and diagnostic approaches for monogenic HDL disorders.
  • Discussion of current management strategies for cardiovascular and renal complications.

Main Results:

  • Monogenic defects in specific genes (APOA1, ABCA1, LCAT, CETP, LIPC, SCARB1) can lead to very low or very high HDL-C levels.
  • Clinical manifestations such as corneal opacities, xanthomas, hepatomegaly, and neuropathy can be indicative of these genetic conditions.
  • Genetic sequencing and biochemical analysis are crucial for definitive diagnosis, particularly in cases of absolute HDL deficiency or early-onset ASCVD.

Conclusions:

  • Monogenic HDL diseases, while rare, necessitate specific diagnostic considerations.
  • Early identification through genetic and biochemical testing is vital for individuals with suggestive clinical or laboratory findings.
  • Management focuses on preventing cardiovascular and renal complications through cholesterol and blood pressure control, as no specific treatment exists for the genetic defects themselves.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
672
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.6K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.2K
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
6.1K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K